Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Advanced Biliary Tract Tumors”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT01752920
What this trial is testing

Phase 1/2 Study of Derazantinib (ARQ 087) in Adult Subjects With Advanced Solid Tumors With FGFR Genetic Alterations

Who this might be right for
Solid Tumor
Basilea Pharmaceutica 119
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06502080
What this trial is testing

Consolidative Radiotherapy (CSRT) in Patients With Oligometastatic/Locally Advanced Unresectable Bilary Tract Cancer (BTC)

Who this might be right for
Biliary Tract Cancer
Shanghai Zhongshan Hospital 128
Testing effectiveness (Phase 2)Study completedNCT00088270
What this trial is testing

OSI-7904L Versus 5-FU/LV as Treatment in Patients With Biliary Tract Cancer

Who this might be right for
Locally Advanced or Metastatic Adenoca of the Biliary Tract
OSI Pharmaceuticals 58
Testing effectiveness (Phase 2)Study completedNCT00084942
What this trial is testing

Gemcitabine and Capecitabine in Treating Patients With Advanced and/or Inoperable Cholangiocarcinoma or Carcinoma of the Gallbladder

Who this might be right for
Extrahepatic Bile Duct CancerGallbladder Cancer
Roswell Park Cancer Institute
Early research (Phase 1)Looking for participantsNCT07812805
What this trial is testing

SKL35501 With SKL35502 Imaging in Adults With NTSR1 Positive Advanced Solid Tumors

Who this might be right for
Selected Advanced Solid TumorsColorectal Cancer (CRC)Pancreatic Ductal Adenocarcinoma (PDAC)+4 more
SK Life Science, Inc. 100
Testing effectiveness (Phase 2)Active Not RecruitingNCT07023731
What this trial is testing

Evaluate ARV-806 in Adults With Advanced Cancer That Has the KRAS G12D Mutation

Who this might be right for
KRAS G12D MutationAdvanced Solid Cancer
Arvinas Inc. 76
Testing effectiveness (Phase 2)Study completedNCT05190575
What this trial is testing

TST001 in Patients With CLDN18.2 Positive Previously Treated Advanced Biliary Tract Cancer

Who this might be right for
Biliary Tract Neoplasms
Shanghai Zhongshan Hospital 8
Testing effectiveness (Phase 2)Study completedNCT00003557
What this trial is testing

Dolastatin 10 in Treating Patients With Metastatic Or Recurrent Liver, Bile Duct, or Gallbladder Cancer

Who this might be right for
Extrahepatic Bile Duct CancerGallbladder CancerLiver Cancer
University of Chicago 16
Early research (Phase 1)Study completedNCT03027284
What this trial is testing

Merestinib (LY2801653) in Japanese Participants With Advanced or Metastatic Cancer

Who this might be right for
Advanced CancerMetastatic CancerBiliary Tract Carcinoma+4 more
Eli Lilly and Company 19
Large-scale testing (Phase 3)Not Yet RecruitingNCT07598318
What this trial is testing

Study of Becotatug Vedotin Added to Standard Treatment for Advanced Bile Duct Cancer With EGFR Mutations

Who this might be right for
Cholangiocarcinoma
Sir Run Run Shaw Hospital 164
Testing effectiveness (Phase 2)Looking for participantsNCT07038343
What this trial is testing

AVENTINE-1: Study of AVZO-1418 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Solid Tumors (AVZO-1418-1001)

Who this might be right for
Solid Tumor CancerLocally AdvancedMetastatic Solid Tumors+5 more
Avenzo Therapeutics, Inc. 480
Testing effectiveness (Phase 2)Study completedNCT01389414
What this trial is testing

Panitumumab Plus Gemcitabine and Oxaliplatin (GEMOX)Versus GEMOX Alone to Treat Advanced Biliary Tract Adenocarcinoma

Who this might be right for
Biliary Carcinoma
Prof. Massimo Aglietta 89
Testing effectiveness (Phase 2)Study completedNCT00021047
What this trial is testing

Epirubicin, Carboplatin, and Capecitabine in Treating Patients With Unresectable Locally Advanced, Metastatic, or Recurrent Solid Tumor

Who this might be right for
Esophageal CancerExtrahepatic Bile Duct CancerGastric Cancer+3 more
National Institutes of Health Clinical Center (CC)
Not applicableEnded earlyNCT00896467
What this trial is testing

Psychological and Emotional Impact in Patients Undergoing Treatment For Metastatic Cancer Either in a Clinical Trial or as Standard Off-Trial Therapy

Who this might be right for
Anal CancerAnxiety DisorderBreast Cancer+9 more
Centre Oscar Lambret 200
Not applicableNot Yet RecruitingNCT07830628
What this trial is testing

Bile ctDNA Genomic Profiling and Concordance With Tumor Tissue in Biliary Tract Cancer

Who this might be right for
Biliary Tract Cancer (BTC)
CHA University 100
Early research (Phase 1)Study completedNCT00027534
What this trial is testing

Vaccine Therapy in Treating Patients With Advanced or Metastatic Cancer

Who this might be right for
Breast CancerColorectal CancerGallbladder Cancer+6 more
Michael Morse, MD 14
Testing effectiveness (Phase 2)Study completedNCT04722133
What this trial is testing

Trastuzumab-pkrb Combined With Modified FOLFOX-6 in Biliary Tract Cancer Patients Progressed on First Line Therapy

Who this might be right for
HER2 Positive Advanced/Metastatic/Nonresectable Biliary Tract Cancer
Yonsei University 36
Testing effectiveness (Phase 2)Active Not RecruitingNCT02151084
What this trial is testing

Different Dosing Schedules of Selumetinib With Cisplatin/Gemcitabine (CIS/GEM) Versus CIS/GEM Alone in Biliary Cancer

Who this might be right for
Biliary Tract CarcinomaGallbladder Carcinoma
University Health Network, Toronto 57
Early research (Phase 1)Study completedNCT03358849
What this trial is testing

Phase 1 Clinical Trial to Evaluate the Safety of Allogeneic NK Cell ("SMT-NK") Cell Therapy in Advanced Biliary Tract Cancer

Who this might be right for
Advanced Biliary Tract Cancer
Yonsei University 9
Testing effectiveness (Phase 2)UnknownNCT05350943
What this trial is testing

HAIC Combined With Toripalimab and Donafenib for Advanced BTC

Who this might be right for
Biliary Tract Adenocarcinoma
Lu Wang, MD, PhD 70
Next Page